Certolizumab in Combination With Chemotherapy for Patients With Stage IV Lung Adenocarcinomas
Status:
Active, not recruiting
Trial end date:
2022-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the safety of certolizumab when it is given with the
chemotherapy drugs cisplatin and pemetrexed. Cisplatin and pemetrexed are two chemotherapy
drugs used in the treatment of lung cancer. The investigators want to find out what effects,
good and/or bad, certolizumab has on the patient and lung cancer.